Boston Children's Hospital
300 Longwood Avenue, Boston, MA, 02115 ยท (617) 735-6000
$2.32B
Net patient revenue, FY 2025
$2.32B
Net patient revenue, FY 2025
Beds
473
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$2.32B
FY 2025
Net income
$64.0M
Patient care margin -22.9%
Discharges
15,187
Occupancy 80.0%
Clinicians
250
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
1 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.32B | $2.85B | -22.9% | $64.0M | 15,187 | - | 0.6% | 50.2% |
| 2024 | $2.01B | $2.57B | -27.8% | -$57.0M | 15,765 | - | 0.6% | 48.9% |
| 2023 | $1.86B | $2.41B | -29.6% | -$126.0M | 15,241 | - | 0.8% | 47.2% |
| 2022 | $1.59B | $2.02B | -27.2% | $89.7M | 13,225 | - | 0.8% | 46.7% |
| 2021 | $1.47B | $1.73B | -17.5% | $75.1M | 12,798 | - | 1.5% | 44.4% |
| 2020 | $1.27B | $1.61B | -27.3% | -$38.2M | 12,514 | - | 1.3% | 42.4% |
Hospital profile
- Medicare certification number (CCN)
- 223302
- Organization NPI
- 1710087127
- Legal name
- Children's Hospital Corporation
- County
- Suffolk County, MA
- Ownership
- Nonprofit (private)
- Teaching
- Major teaching
- In Medicare since
- 1986
- Full-time employees
- 11,043
- Health system
- Boston Childrens Hospital
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other hospitals in Boston
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 5112 Level 2 Musculoskeletal Procedures | - | - | - | $1,196.16 |
| APC 5113 Level 3 Musculoskeletal Procedures | - | - | - | $2,373.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | - | - | - | $5,338.75 |
| APC 5153 Level 3 Airway Endoscopy | - | - | - | $1,264.08 |
| APC 5165 Level 5 ENT Procedures | - | - | - | $4,436.36 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5191 Level 1 Endovascular Procedures | - | - | - | $2,207.96 |
| APC 5192 Level 2 Endovascular Procedures | - | - | - | $4,338.16 |
| APC 5193 Level 3 Endovascular Procedures | - | - | - | $8,873.86 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $9.1M |
| E.R. Squibb & Sons, L.L.C. | 7 | $3.0M |
| Pfizer Inc. | 32 | $2.7M |
| Vertex Pharmaceuticals Incorporated | 12 | $1.7M |
| Fresenius Kabi USA, LLC | 4 | $1.1M |
| Ultragenyx Pharmaceutical Inc. | 64 | $988K |
| Miach Orthopaedics, Inc. | 2 | $878K |
| Merck Sharp & Dohme LLC | 4 | $724K |
| Sanofi-Aventis U.S. LLC | 3 | $721K |
| Novartis Pharmaceuticals Corporation | 18 | $569K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.